Supplement for: Human Papillomavirus Vaccination Coverage and Keratinocyte Carcinoma Among Kidney Transplant Recipients: A Retrospective Cohort Study
Published: 6 September 2026| Version 1 | DOI: 10.17632/npgy7zyx8n.1
Contributor:
Description
Supplementary Table I: HPV vaccine eligibility criteria applied to study cohort Supplementary Figure 1: Cohort selection flowchart for HPV vaccine-eligible kidney transplant recipients Supplementary Methods: Detailed methods Supplementary Figure 2: Skin cancer–free survival among kidney transplant recipients by HPV vaccination status Supplementary File 1: TriNetX query for external validation
Files
Institutions
- Duke University HospitalNorth Carolina, Durham
Categories
Skin Cancer, Human Papillomavirus Related Disease, Patient with Solid Organ Transplantation